Literature DB >> 27759028

BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.

Maria Coakley1, Vicki Cleary1, Nicholas Power1, Seamus O'Reilly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27759028      PMCID： PMC5255943          DOI： 10.1038/ejhg.2016.138

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  7 in total

1.  BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Authors:  Tuya Pal; Jenny Permuth-Wey; Judith A Betts; Jeffrey P Krischer; James Fiorica; Hector Arango; James LaPolla; Mitchell Hoffman; Martin A Martino; Katie Wakeley; George Wilbanks; Santo Nicosia; Alan Cantor; Rebecca Sutphen
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

2.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Authors:  Kathryn Alsop; Sian Fereday; Cliff Meldrum; Anna deFazio; Catherine Emmanuel; Joshy George; Alexander Dobrovic; Michael J Birrer; Penelope M Webb; Colin Stewart; Michael Friedlander; Stephen Fox; David Bowtell; Gillian Mitchell
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

3.  Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.

Authors:  Stephanie A Cohen; Monica L Marvin; Bronson D Riley; Hetal S Vig; Julie A Rousseau; Shanna L Gustafson
Journal:  J Genet Couns       Date:  2013-04-25       Impact factor: 2.537

4.  AGO Austria recommendations for genetic testing of patients with ovarian cancer.

Authors:  Christian Marth; Michael Hubalek; Edgar Petru; Stephan Polterauer; Alexander Reinthaller; Christian Schauer; Tonja Scholl-Firon; Christian F Singer; Johannes Zschocke; Alain G Zeimet
Journal:  Wien Klin Wochenschr       Date:  2015-08       Impact factor: 1.704

5.  BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.

Authors:  Hildegunn Høberg-Vetti; Cathrine Bjorvatn; Bent E Fiane; Turid Aas; Kathrine Woie; Helge Espelid; Tone Rusken; Hans Petter Eikesdal; Wenche Listøl; Marianne T Haavind; Per M Knappskog; Bjørn Ivar Haukanes; Vidar M Steen; Nicoline Hoogerbrugge
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

6.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Authors:  Peter C Fong; David S Boss; Timothy A Yap; Andrew Tutt; Peijun Wu; Marja Mergui-Roelvink; Peter Mortimer; Helen Swaisland; Alan Lau; Mark J O'Connor; Alan Ashworth; James Carmichael; Stan B Kaye; Jan H M Schellens; Johann S de Bono
Journal:  N Engl J Med       Date:  2009-06-24       Impact factor: 91.245

7.  Selecting a BRCA risk assessment model for use in a familial cancer clinic.

Authors:  Seema M Panchal; Marguerite Ennis; Sandra Canon; Louise J Bordeleau
Journal:  BMC Med Genet       Date:  2008-12-22       Impact factor: 2.103
  7 in total
  2 in total

1.  Impact of Appointment Waiting Time on Attendance Rates at a Clinical Cancer Genetics Service.

Authors:  Tarryn Shaw; Julie Metras; Zoe Ang Li Ting; Eliza Courtney; Shao-Tzu Li; Joanne Ngeow
Journal:  J Genet Couns       Date:  2018-05-24       Impact factor: 2.537

2.  A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.

Authors:  Terri Patricia McVeigh; Karl J Sweeney; Donal J Brennan; Una M McVeigh; Simon Ward; Ann Strydom; Sheila Seal; Katherine Astbury; Paul Donnellan; Joanne Higgins; Maccon Keane; Michael J Kerin; Carmel Malone; Pauline McGough; Ray McLaughlin; Michael O'Leary; Margaret Rushe; Michael Kevin Barry; Geraldine MacGregor; Michael Sugrue; Ala Yousif; Dhafir Al-Azawi; Eileen Berkeley; Terence J Boyle; Elizabeth M Connolly; Carmel Nolan; Elaine Richardson; Claire Giffney; Samantha B Doyle; Sheila Broderick; William Boyd; Ruaidhri McVey; Thomas Walsh; Michael Farrell; David J Gallagher; Nazneen Rahman; Angela J George
Journal:  Fam Cancer       Date:  2022-08-27       Impact factor: 2.446
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.